Galen of Pergamon, treating gladiators in second-century Rome, recorded the use of silk cords to ligate severed blood vessels. Surgical silk offered unmatched tensile strength compared to linen or dried animal gut. The fibers held knots securely under hydraulic arterial pressure. Even then, surgeons observed that clean silk appeared to stimulate flesh formation faster than vegetable cordage, unaware that they were witnessing the early stages of cell scaffolding.
Those ancient applications carried severe risks. Natural silk harvested from Bombyx mori cocoons is not a single uniform substance. It is a biological composite composed of two parallel filaments coated in a sticky glycoprotein binder. When ancient physicians applied unprocessed threads to internal tissue, patients frequently suffered granulomas, persistent suppuration, and tissue necrosis. The material remained valuable for superficial emergency wound closure, but its internal utility stalled for centuries due to recurring infection profiles.
The 19th-century rise of sterile surgical protocol brought silk into mainstream hospital operating theaters. Even with carbolic sterilization, medical silk sutures retained a reputation for delayed tissue rejection. Surgeons accepted this calculated trade-off because synthetic polymers like nylon and polyester did not exist, and gut sutures degraded unpredictably in wet environments.
